Cargando…

Apolipoprotein B100 is required for hepatitis C infectivity and Mipomersen inhibits hepatitis C

AIM: To characterize the role of apolipoprotein B100 (apoB100) in hepatitis C viral (HCV) infection. METHODS: In this study, we utilize a gene editing tool, transcription activator-like effector nucleases (TALENs), to generate human hepatoma cells with a stable genetic deletion of APOB to assess of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schaefer, Esperance A K, Meixiong, James, Mark, Christina, Deik, Amy, Motola, Daniel L, Fusco, Dahlene, Yang, Andrew, Brisac, Cynthia, Salloum, Shadi, Lin, Wenyu, Clish, Clary B, Peng, Lee F, Chung, Raymond T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2016
Materias:	Basic Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143762/ https://www.ncbi.nlm.nih.gov/pubmed/28018102 http://dx.doi.org/10.3748/wjg.v22.i45.9954

Ejemplares similares

MicroRNA 130a Regulates both Hepatitis C Virus and Hepatitis B Virus Replication through a Central Metabolic Pathway
por: Duan, Xiaoqiong, et al.
Publicado: (2018)

Intermittent hypoxia is a proinflammatory stimulus resulting in IL‐6 expression and M1 macrophage polarization
por: Schaefer, Esperance, et al.
Publicado: (2017)

HCV induces transforming growth factor β1 through activation of endoplasmic reticulum stress and the unfolded protein response
por: Chusri, Pattranuch, et al.
Publicado: (2016)

Clinical and Preclinical Pharmacokinetics and Pharmacodynamics of Mipomersen (Kynamro(®)): A Second-Generation Antisense Oligonucleotide Inhibitor of Apolipoprotein B
por: Geary, Richard S., et al.
Publicado: (2015)

Polymorphisms and resistance mutations of hepatitis C virus on sequences in the European hepatitis C virus database
por: Kliemann, Dimas Alexandre, et al.
Publicado: (2016)

Mipomersen and other therapies for the treatment of severe familial hypercholesterolemia
por: Bell, Damon A, et al.
Publicado: (2012)

Autoantibody profiles in autoimmune hepatitis and chronic hepatitis C identifies similarities in patients with severe disease
por: Amin, Kawa, et al.
Publicado: (2017)

Hepatitis C virus antigens enzyme immunoassay for one-step diagnosis of hepatitis C virus coinfection in human immunodeficiency virus infected individuals
por: Hu, Ke-Qin, et al.
Publicado: (2019)

The Role of the Phosphatidylinositol 4-Kinase PI4KA in Hepatitis C Virus-Induced Host Membrane Rearrangement
por: Tai, Andrew W., et al.
Publicado: (2011)

Low Complement C4 Predicts Improvement of Kidney Function After Direct‐Acting Antiviral Therapy for Hepatitis C Virus
por: Sise, Meghan E., et al.
Publicado: (2020)

Estrogen receptor expression in chronic hepatitis C and hepatocellular carcinoma pathogenesis
por: Iyer, Janaki K, et al.
Publicado: (2017)

Planning the hepatitis C virus elimination in Cyprus: A modeling study
por: Gountas, Ilias, et al.
Publicado: (2021)

Expression of Apoptosis Regulatory Markers in the Skin of Advanced Hepatitis-C Virus Liver Patients
por: El-Domyati, Moetaz, et al.
Publicado: (2012)

Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C
por: Hernández-Bartolomé, Ángel, et al.
Publicado: (2016)

Hepatitis C virus NS5A region mutation in chronic hepatitis C genotype 1 patients who are non-responders to two or more treatments and its relationship with response to a new treatment
por: Muñoz de Rueda, Paloma, et al.
Publicado: (2017)

Gene expression and hepatitis C virus infection
por: Asselah, T, et al.
Publicado: (2009)

Reactivation of a Vaccine Escape Hepatitis B Virus Mutant in a Cambodian Patient During Anti-Hepatitis C Virus Therapy
por: Fusco, Dahlene N., et al.
Publicado: (2018)

Mipomersen in Familial Hypercholesterolemia: An Update on Health-Related Quality of Life and Patient-Reported Outcomes
por: Chambergo-Michilot, Diego, et al.
Publicado: (2022)

Tissue expression of β-catenin and E- and N-cadherins in chronic hepatitis C and hepatocellular carcinoma
por: Kasprzak, Aldona, et al.
Publicado: (2017)

Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals
por: Gountas, Ilias, et al.
Publicado: (2019)

(-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes
por: Wang, Yi-Zhong, et al.
Publicado: (2017)

Mipomersen, an apolipoprotein B synthesis inhibitor, lowers low-density lipoprotein cholesterol in high-risk statin-intolerant patients: a randomized, double-blind, placebo-controlled trial
por: Visser, Maartje E., et al.
Publicado: (2012)

Influence of TBX21 T-1993C variant on autoimmune hepatitis development by Yin-Yang 1 binding
por: Sun, Wei, et al.
Publicado: (2017)

Prevalence of IFNL3 rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C
por: Świątek-Kościelna, Bogna, et al.
Publicado: (2017)

TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype
por: Sagnelli, Caterina, et al.
Publicado: (2016)

Mipomersen: evidence-based review of its potential in the treatment of homozygous and severe heterozygous familial hypercholesterolemia
por: Parhofer, Klaus G
Publicado: (2012)

Apolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion
por: Fisher, Eric, et al.
Publicado: (2014)

Gadofullerene inhibits the degradation of apolipoprotein B100 and boosts triglyceride transport for reversing hepatic steatosis
por: Zhou, Chen, et al.
Publicado: (2020)

Hemodynamic changes in hepatic sinusoids of hepatic steatosis mice
por: Fan, Jing, et al.
Publicado: (2019)

Fibrosis in Chronic Hepatitis C: Correlation between Immunohistochemically-Assessed Virus Load with Steatosis and Cellular Iron Content
por: Akl, Maha, et al.
Publicado: (2016)

Cell culture-adaptive mutations in hepatitis C virus promote viral production by enhancing viral replication and release
por: Wang, Qi, et al.
Publicado: (2018)

Hepatic microenvironment underlies fibrosis in chronic hepatitis B patients
por: Yao, Qun-Yan, et al.
Publicado: (2020)

MicroRNA profile and iron-related gene expression in hepatitis C-related hepatocellular carcinoma: a preliminary study
por: Krupa, Renata, et al.
Publicado: (2019)

Amphipathic α-Helices in Apolipoproteins Are Crucial to the Formation of Infectious Hepatitis C Virus Particles
por: Fukuhara, Takasuke, et al.
Publicado: (2014)

Hepatitis B virus inhibits the in vivo and in vitro synthesis and secretion of apolipoprotein C3
por: Zhu, Chengliang, et al.
Publicado: (2017)

Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis?
por: Bridge, Simon H., et al.
Publicado: (2018)

Apolipoprotein(a) inhibits hepatitis C virus entry through interaction with infectious particles
por: Oliveira, Catarina, et al.
Publicado: (2017)

The Effect of Mipomersen in the Management of Patients with Familial Hypercholesterolemia: A Systematic Review and Meta-Analysis of Clinical Trials
por: Astaneh, Behrooz, et al.
Publicado: (2021)

Conservation and variability of hepatitis B core at different chronic hepatitis stages
por: Yll, Marçal, et al.
Publicado: (2020)

Tumor necrosis factor-α -G308A polymorphism is associated with liver pathological changes in hepatitis C virus patients
por: Bader El Din, Noha G, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rkto4ch3cndl5o8ek8eo5nq9af